Skip to main content

4 Vaccines Seniors 65+ Need This Fall 2026

Chart comparing age eligibility for flu, COVID-19, RSV, and shingles vaccines in adults 65 and older, with Medicare Part B and Part D coverage noted

Last updated: September 3, 2026

[Key Takeaways]

  • The CDC has not issued clear, updated fall 2026 guidance on flu, RSV, or COVID-19 vaccines for adults 65 and older, leaving a gap that professional medical groups have stepped in to address.
  • The American Medical Association and the University of Minnesota's Vaccine Integrity Project have published their own seasonal vaccine guidance for clinicians and patients.
  • Adults 65+ are generally steered toward high-dose or adjuvanted flu vaccines rather than standard-dose shots, and a new mRNA flu vaccine is now an additional option.
  • RSV vaccination is routinely recommended for adults 75+ and for adults 50-74 with qualifying risk factors; adults 60-74 without those risk factors are not currently recommended to receive it under guidance in effect since a June 2024 update.
  • Medicare Part B covers one flu shot and a COVID-19 vaccine each season at no cost, while RSV and shingles vaccine coverage can vary by plan and is worth confirming directly.
This article is intended for general informational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Please consult a licensed healthcare professional regarding your own health situation.

It is written in the hope that it can be of even a little help to many readers.

Overview

Fall vaccine season usually comes with a straightforward checklist from federal health authorities. This year is different. For adults 65 and older, deciding which vaccines to get — and when — requires more legwork than usual, because the usual source of clear federal guidance has gone quiet on several fronts. This guide walks through what has changed, what medical organizations are recommending instead, and how flu, RSV, COVID-19, and shingles vaccines stack up for seniors heading into fall 2026.

Fall 2026 Vaccines for Seniors: No Clear CDC Recommendation This Year

In previous years, the CDC's Advisory Committee on Immunization Practices (ACIP) published seasonal guidance each summer that pharmacies, primary care offices, and Medicare plans all followed as the default playbook. For fall 2026, that playbook is incomplete. Leadership changes and shifting priorities at the federal level have delayed or narrowed several of the usual recommendations for flu, RSV, and COVID-19 vaccination, leaving both clinicians and patients without a single, unified source to check.[1]

[1] Georgetown CCF, "Court Order Presses Pause on New ACIP Committee..." (2026); STAT News, "New rules for CDC vaccine panel..." (2026)

This is a meaningful shift for adults 65 and older, a group that has historically been advised to get vaccinated every fall almost automatically. Without a clear federal signal, some patients may be unsure whether the guidance changed because the science changed, or for other reasons. It is worth noting that the underlying case for vaccinating older adults against respiratory illness has not been overturned — what has changed is the process for issuing formal recommendations.

How AMA and the Vaccine Integrity Project Are Filling the Gap

Into that gap, professional medical organizations have stepped forward. The American Medical Association (AMA) has issued its own seasonal vaccination guidance for physicians and patients, explicitly framing it as a response to the absence of timely federal recommendations.[1] Separately, a coalition of public health experts organized as the Vaccine Integrity Project, housed at the University of Minnesota's Center for Infectious Disease Research and Policy, has also published independent recommendations intended to give clinicians a scientifically grounded reference point when federal guidance is delayed or unclear.[1]

[1] AMA press release, "AMA, Vaccine Integrity Project launch vaccine review..." (2026); CIDRAP, "Vaccine Integrity Project, AMA review COVID, flu, and RSV vaccines" (2026)

These groups are not government agencies, so their guidance does not carry regulatory weight in the same way ACIP recommendations traditionally have. However, they are composed of physicians and public health researchers who have historically contributed to the same evidence base ACIP relies on, which is why many hospital systems, pharmacy chains, and individual physicians are treating this guidance as a reasonable working substitute this season.

How to Decide With Your Doctor When Federal Guidance Is Unclear

For a senior trying to plan fall vaccinations, the practical takeaway is that the decision now leans more heavily on a conversation with a primary care provider or pharmacist rather than a single federal checklist. A few steps can make that conversation more productive:

Bring your vaccination history. Knowing which flu formulation, RSV dose, and COVID-19 booster you have already received helps your provider assess what, if anything, is due this fall.

Ask about your specific risk factors. Chronic lung disease, heart disease, diabetes, and a weakened immune system all can affect which vaccines are prioritized for you, independent of what general guidance says.

Check with your pharmacy as well as your doctor. Many chain and independent pharmacies are following the AMA or Vaccine Integrity Project guidance directly and can tell you what is currently in stock and covered.

Confirm coverage before you go. Because Medicare and private insurance coverage rules can shift along with federal recommendations, it is worth a quick call to your plan to confirm no-cost coverage before your appointment.

At a Glance: Vaccine Recommendations for Adults 65+

The table below summarizes where things stand for the four vaccines most relevant to adults 65 and older this fall. Because federal guidance is unsettled in places, "recommendation status" reflects the current consensus from AMA and Vaccine Integrity Project guidance where CDC guidance is unclear.[1]

[1] AMA press release, "AMA, Vaccine Integrity Project launch vaccine review..." (2026); CIDRAP, "Vaccine Integrity Project, AMA review COVID, flu, and RSV vaccines" (2026)

Vaccine Type Recommended Age Group Recommendation Status Medicare Coverage
Flu All adults 65+ High-dose or adjuvanted formula preferred; annual Covered in full, once per season
RSV 75+ (routine); 50-74 (high risk only) Single lifetime dose, risk-based since June 2024 Varies by plan (Part D)
COVID-19 All adults 65+, especially high risk Federal guidance unclear this season Covered in full under Part B (same as flu)
Shingles Adults 50+ Two-dose series; not new to this season Typically Part D or Medicare Advantage

Flu Vaccine Options: High-Dose, Adjuvanted, or mRNA

Flu vaccination remains one of the more settled pieces of fall vaccine planning for seniors, even amid the broader guidance gap. Adults 65 and older have had access to flu vaccines formulated specifically for older immune systems for more than a decade, and that general approach has not changed this season.

Why Standard-Dose Flu Shots Aren't Recommended After 65

The immune system's response to vaccination tends to weaken with age, a process sometimes referred to as immunosenescence. This can make the standard-dose flu vaccine less effective at generating a protective antibody response in adults 65 and older compared with younger adults.[1] To help close that gap, two alternative formulations were developed for this age group: a high-dose vaccine that contains a larger quantity of antigen, and an adjuvanted vaccine that includes an added ingredient designed to strengthen the immune response.[1] Research comparing these formulations to the standard dose in older adults has generally found improved immune response, which is why pharmacies and clinics typically offer high-dose or adjuvanted options by default once a patient turns 65.

[1] Crooke et al., "Understanding immunosenescence...," Vaccine (2020); "High-dose influenza vaccine in older adults..." (meta-analysis update) (2023)

The New mRNA Flu Vaccine, Briefly

In August 2026, the FDA approved the first mRNA-based flu vaccine for use in adults, adding a new option alongside the traditional high-dose and adjuvanted shots.[1] For adults 65 and older weighing this newer option against the established high-dose and adjuvanted formulations, the tradeoffs are worth understanding before deciding which to request at a pharmacy or physician's office this season.

[1] STAT News, "FDA approves Moderna's mRNA flu vaccine..." (2026)

RSV Vaccination: Who Needs It and When

RSV (respiratory syncytial virus) vaccine guidance for older adults has evolved since the vaccines first became available, and it now differs by age and health status rather than applying uniformly to everyone 60 and older.

For adults 75 and older, a single dose of an RSV vaccine is recommended for essentially the entire group, reflecting the higher risk of severe illness and hospitalization from RSV that comes with advanced age.[1] For adults ages 50 to 74 who have chronic conditions that raise their risk of severe RSV illness — such as chronic heart or lung disease, diabetes, or a weakened immune system — a single dose is also recommended.[1] For adults ages 60 to 74 without those specific risk factors, current guidance does not recommend RSV vaccination at this time. This is a change from the vaccine's original 2023 rollout, when a broader "shared clinical decision-making" category briefly applied to this group; ACIP narrowed the recommendation to a risk-based approach in June 2024, and that risk-based framework remains in effect for the 2026-2027 season.[1]

[1] CIDRAP, "CDC panel revises RSV vaccine recommendations for adults" (2024); Pharmacy Times, "New ACIP Recommendations for RSV Vaccines..." (2024)

Unlike flu vaccination, RSV vaccination is currently a single lifetime dose rather than an annual shot, though this guidance may be revisited over time as more data on how long protection lasts becomes available. If you already received an RSV vaccine in a previous season, it is generally not necessary to repeat it this fall — but it is worth confirming with your provider, particularly if you are unsure whether you qualify under the current risk-based criteria.

COVID-19 and Shingles: Other Vaccines to Check Off This Fall

Two more vaccines are worth reviewing during a fall checkup, even though neither is at the center of this year's guidance gap in the same way flu and RSV are.

COVID-19 booster recommendations for the 2026-2027 season have been affected by the same lack of clear federal direction described earlier in this guide. For adults 65 and older, and particularly those with chronic conditions that raise the risk of severe COVID-19, a number of physician groups continue to recommend staying current with an updated booster targeting circulating variants, even without a unified CDC announcement.[1] Because eligibility windows and formulations can shift, confirming current availability with a pharmacy or physician before assuming you are due (or not due) is a reasonable step this season.

[1] AARP, "FDA Approves Updated COVID Vaccines for 2026-2027" (2026); Medical Daily, "Four Physician Groups Issue Fall Flu, COVID, and RSV Vaccine Advice..." (2026)

Shingles vaccination is a separate matter and is not affected by this year's guidance gap. The recommendation for adults 50 and older to complete a two-dose shingles vaccine series, spaced several months apart, remains in place.[1] Because the risk of a first shingles episode increases with age, and having had shingles once does not prevent future occurrences, a fall checkup is a reasonable time to confirm whether you have completed both doses, particularly if you started the series and are unsure whether you finished it.[1]

[1] CDC, "Shingles Vaccine Recommendations"; JAAD, "Risk of recurrent herpes zoster in a population-based cohort study of older adults" (2020)

Medicare Coverage for Fall Vaccines

Cost is often the deciding factor in whether a vaccine actually gets scheduled, so it is worth understanding how Medicare treats each of these four vaccines differently.

Medicare Part B covers one flu vaccine per season, and a COVID-19 vaccine, both at no cost to the beneficiary as long as the provider accepts Medicare assignment — regardless of which flu formulation (standard, high-dose, adjuvanted, or the newer mRNA option) is administered.[1] This is one of the more stable pieces of coverage this season and has not been affected by the broader guidance uncertainty.

[1] MedicareFAQ, "What Vaccines Does Medicare Cover? Part B vs. Part D" (2026); NCOA, "Are Vaccines Free With Medicare and Medicaid? What's Covered"

RSV and shingles vaccines are handled differently: rather than falling under Part B, they typically fall under Part D (or a Medicare Advantage plan's drug benefit), where out-of-pocket costs can vary depending on the plan's formulary and where the vaccine is administered.[1] Because coverage rules can also shift when federal guidance changes, the most reliable way to confirm what you will pay is to check directly with Medicare.gov or call 1-800-MEDICARE before scheduling an appointment, rather than assuming coverage matches what a friend or family member experienced.

[1] MedicareFAQ, "What Vaccines Does Medicare Cover? Part B vs. Part D" (2026); NCOA, "Are Vaccines Free With Medicare and Medicaid? What's Covered"

References

  1. Georgetown CCF, "Court Order Presses Pause on New ACIP Committee and Changes to Childhood Vaccination Schedule" (2026) — https://ccf.georgetown.edu/2026/03/31/court-order-presses-pause-on-new-acip-committee-and-changes-to-childhood-vaccination-schedule/
  2. STAT News, "New rules for CDC vaccine panel aim to address lawsuit, empower Kennedy's allies" (2026) — https://www.statnews.com/2026/04/09/new-acip-charter-cdc-vaccine-advisers-rfk-jr-address-legal-defeat/
  3. AMA press release, "AMA, Vaccine Integrity Project launch vaccine review for next respiratory season" (2026) — https://www.ama-assn.org/press-center/ama-press-releases/ama-vaccine-integrity-project-launch-vaccine-review-next
  4. CIDRAP, "Vaccine Integrity Project, American Medical Association review COVID, flu, and RSV vaccines" (2026) — https://www.cidrap.umn.edu/vaccine-integrity-project/vaccine-integrity-project-american-medical-association-review-covid-flu
  5. Crooke SN, Ovsyannikova IG, Poland GA, Kennedy RB, "Understanding immunosenescence and its impact on vaccination of older adults," Vaccine (2020). PMID 33229108 — https://pubmed.ncbi.nlm.nih.gov/33229108/
  6. "High-dose influenza vaccine in older adults by age and seasonal characteristics: Systematic review and meta-analysis update" (2023). PMID 37333054 — https://pubmed.ncbi.nlm.nih.gov/37333054/
  7. STAT News, "FDA approves Moderna's mRNA flu vaccine, the first to use the technology" (2026) — https://www.statnews.com/2026/08/05/fda-approves-moderna-mflusiva-first-mrna-flu-vaccine/
  8. CIDRAP, "CDC panel revises RSV vaccine recommendations for adults" (2024) — https://www.cidrap.umn.edu/respiratory-syncytial-virus-rsv/cdc-panel-revises-rsv-vaccine-recommendations-adults
  9. Pharmacy Times, "New ACIP Recommendations for RSV Vaccines Aim to Solve Challenges With Shared Clinical Decision-Making" (2024) — https://www.pharmacytimes.com/view/new-acip-recommendations-for-rsv-vaccines-aim-to-solve-challenges-with-shared-clinical-decision-making
  10. AARP, "FDA Approves Updated COVID Vaccines for 2026-2027" (2026) — https://www.aarp.org/health/conditions-treatments/fda-approves-newest-covid-vaccines/
  11. Medical Daily, "Four Physician Groups Issue Fall Flu, COVID, and RSV Vaccine Advice While the Federal Panel Stays Sidelined" (2026) — https://www.medicaldaily.com/fall-vaccine-recommendations-2026-flu-covid-rsv-478151
  12. CDC, "Shingles Vaccine Recommendations" — https://www.cdc.gov/shingles/hcp/vaccine-considerations/index.html
  13. JAAD, "Risk of recurrent herpes zoster in a population-based cohort study of older adults" (2020) — https://www.jaad.org/article/S0190-9622(20)32114-9/abstract
  14. MedicareFAQ, "What Vaccines Does Medicare Cover? Part B vs. Part D" (2026) — https://www.medicarefaq.com/faqs/medicare-part-d-part-b-vaccines/
  15. NCOA, "Are Vaccines Free With Medicare and Medicaid? What's Covered" — https://www.ncoa.org/article/medicare-and-medicaid-now-fully-cover-preventive-vaccines/

Related Reading

Labels:

Comments

Post a Comment

Popular posts from this blog

2026 Cyclospora Lettuce Recall: 4 Steps to Check

[Key Takeaways]  A multistate cyclosporiasis outbreak linked to recalled iceberg lettuce has sickened at least 6,358 people across 15 states as of the most recent CDC update, including at least 278 hospitalizations and 2 deaths. The recalled lettuce — supplied by Taylor Farms de Mexico, sold under Walmart's Marketside brand, and served as shredded lettuce at some Taco Bell locations — was distributed to at least 27 states. Cyclospora cayetanensis, the parasite responsible for the illness, spreads mainly through contaminated fresh produce or water rather than through casual contact between people. Common symptoms include watery diarrhea, stomach cramping, bloating, fatigue, and low-grade fever; untreated infections may last anywhere from a few days to a month or longer and can recur after seeming to improve. Checking current recall notices and following basic food safety steps may help lower your risk of infection. This article is intended for general informational pu...
Post a Comment
Read more

Heat Waves and Elderly Mental Health: 4 Warning Signs

[Key Takeaways] A 2026 study of more than 2.6 million psychiatric hospital admissions across four countries found an association between extreme heat and higher rates of psychiatric hospitalization. The association appears more pronounced among older adults and residents of less densely populated areas; separate research has also examined heat-related mortality risk among adults 65 and older, with disproportionate effects reported in Black communities and lower-income households. Older adults taking certain medications — including diuretics, anticholinergic drugs, and lithium — may face added heat-related health risks. Four warning signs may signal heat-related mental health distress in seniors: confusion or disorientation, unusual anxiety or agitation, worsening depression symptoms, and physical symptoms that overlap with heat exhaustion. With heat waves expected to continue into August and September in many parts of the U.S., now is a good time to review prevention steps...
Post a Comment
Read more

MMR Vaccine Split Order: What Parents Should Know Now

[Key Takeaways]  On August 10, 2026, President Trump signed an executive order directing federal health agencies to make individual measles, mumps, and rubella vaccines available separately instead of only as the combined MMR shot. The order was reported by at least six major outlets — including Axios, CIDRAP, CNBC, Healthline, ABC News, and NBC News — within days of signing, and organizations such as the American Academy of Pediatrics have raised concerns about the change. The CDC has recorded 2,465 confirmed measles cases across 38 outbreaks in 2026, the highest case count in 35 years, with 93% of cases occurring in people who were not vaccinated. Kindergarten MMR vaccination coverage fell to 92.5% for the 2024-2025 school year, down from 95.2% in 2019-2020. Parents and guardians can take several concrete steps now, from checking vaccination records to knowing early measles symptoms. This article is intended for general informational purposes and is not a substitut...
Post a Comment
Read more

Chipotle Salmonella Outbreak: 4 Signs You Should Know

[Key Takeaways] As of August 2026, CDC and FDA officials reported 345 Salmonella infections across 27 states linked to jalapeños served at Chipotle and Qdoba locations, with 36 hospitalizations and no deaths reported. Both chains have removed jalapeños from their menus nationwide as a precaution while the investigation continues. Common symptoms include diarrhea, fever, abdominal cramps, and vomiting, and most people recover within 4 to 7 days without specific treatment. Bloody diarrhea, a high fever lasting more than three days, or signs of dehydration are warning signs that call for prompt medical care. Investigations are ongoing, so check the CDC and FDA outbreak pages directly for the most current information. This article is intended for general informational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Please consult a licensed healthcare professional regarding your own health situation. It is written in the hope that i...
Post a Comment
Read more

How Long Does a Cold Last? Normal Timeline and Warning Signs

Last updated: August 19, 2026  [Key Takeaways] Most colds last about 7 to 10 days, though a lingering cough or stuffy nose can persist for 2 to 3 weeks in some cases. Symptoms typically peak between days 4 and 7 before gradually improving. Feeling better and then suddenly getting worse again is not a normal cold pattern and may point to a secondary infection. A high fever above 102°F (about 39°C) that lasts more than 3 to 4 days—especially with facial pain or thick nasal discharge—along with trouble breathing or symptoms persisting beyond 10 to 14 days, are reasons to contact a healthcare provider. Rest, fluids, and over-the-counter symptom relief are usually enough for a cold that is following its normal course. This article is intended for general informational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Please consult a licensed healthcare professional regarding your own health situation. It is written in the hope th...
Post a Comment
Read more

Screen Time Over 4 Hours: Mental Health Risks for Kids

[Key Takeaways]  A January 2026 study in a Nature Portfolio journal analyzed screen-use data from 50,231 U.S. children and teens ages 6-17 using the National Survey of Children's Health. Kids using screens 4 or more hours a day showed a 45% higher likelihood of anxiety and a 61% higher likelihood of depression compared with lower-use peers. The same high-use group also showed a 24% higher likelihood of behavior or conduct problems and a 21% higher likelihood of ADHD. The study is correlational and based on parent-reported survey data, so it cannot prove that screen time causes these outcomes. In May 2026, the U.S. Surgeon General issued a public health advisory on excessive screen use in children and teens, and parents have several practical tools available to help manage daily screen habits. This article is intended for general informational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Please consult a licensed healthcar...
Post a Comment
Read more

Young Adults' Mental Health: 36% Rate It Fair or Poor

[Key Takeaways]  36% of U.S. adults under 30 rate their own mental health as fair or poor, compared with 9% of adults 65 and older — roughly four times higher. Low-income adults report a similarly high rate, at 32%, though the original data does not fully separate age and income effects. Researchers point to factors such as financial pressure, social media use, and lingering post-pandemic disruption as possibly associated with the pattern, without establishing direct cause and effect. A "fair or poor" self-rating reflects personal perception, not a clinical diagnosis — it is a signal to consider, not a medical conclusion. Practical steps, from daily routines to therapy, telehealth, and campus or workplace resources, may help young adults address low self-rated mental health. This article is intended for general informational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Please consult a licensed healthcare profession...
Post a Comment
Read more

Cold or Flu? 5 Symptom Differences to Check First

[Key Takeaways]  Cold and flu share many early symptoms, but onset speed, fever intensity, and fatigue level often help tell them apart. Flu tends to start suddenly with high fever, body aches, and pronounced fatigue, while colds usually build gradually with a runny nose and sneezing. Rapid antigen tests and PCR testing at a healthcare provider's office offer a more reliable way to confirm which virus is involved than symptoms alone. Difficulty breathing, chest pain, or a fever that will not resolve are warning signs that call for prompt medical attention. Frequent handwashing and annual flu vaccination are among the most consistently recommended everyday prevention steps. This article is intended for general informational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Please consult a licensed healthcare professional regarding your own health situation. It is written in the hope that it can be of even a little help to many...
Post a Comment
Read more

Sugary Drinks Linked to 2.45x Higher Stomach Cancer Risk

Last updated: August 21, 2026  [Key Takeaways] A decades-long study of 112,284 US adults, drawing on data from the Nurses' Health Study and the Health Professionals Follow-Up Study, examined the link between sugary drink consumption and stomach cancer. Adults who drank sugar-sweetened beverages more than once a day had a hazard ratio of 2.45 (95% CI 1.49–4.04) for stomach cancer compared to those who rarely or never drank them. Artificially sweetened (diet) drinks were not associated with an increased risk in this study. Researchers say this is the first US-based study to report this particular association. Switching toward unsweetened beverages may be worth discussing with a healthcare provider, especially for people with additional risk factors. This article is intended for general informational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Please consult a licensed healthcare professional regarding your own health situ...
Post a Comment
Read more

Weekly Health Briefs — Egg Recall Escalates, Raw Milk Outbreak Widens (Aug. 10-16, 2026)

Keywords: egg recall salmonella, raw milk outbreak, COVID variant BA.3.2, PTSD cannabis treatment, strength training longevity  This article is intended for general informational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Please consult a licensed healthcare professional regarding your own health situation. It is written in the hope that it can be of even a little help to many readers. Overview This week's roundup covers five stories worth knowing about: an egg recall that just jumped to the FDA's most serious risk category, a raw milk outbreak in Idaho unfolding just as more states move to loosen raw milk sales rules, a heavily mutated COVID variant now confirmed in 31 states, early clinical trial results for a cannabis-derived treatment for PTSD nightmares, and a Harvard study on strength training and longevity getting renewed attention this month. [This Week at a Glance] 1. Egg Salmonella Recall Escalates to FD...
Post a Comment
Read more